Novo Nordisk has appointed Danish national Jens Pii Olesen as general manager of Novo Nordisk Turkiye, according to a post on social media Linkedin.
He will take over the role from Burak Cem, who has held the title since January 2016 and has more than 20 years of experience at Novo Nordisk.
More from MedWatch
In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.